中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
2-羟基-3-甲氧基-5-甲基苯甲醛 | 2-hydroxy-3-methoxy-5-methylbenzaldehyde | 7452-10-0 | C9H10O3 | 166.177 |
邻香草醛 | 3-methoxy-2-hydroxybenzaldehyde | 148-53-8 | C8H8O3 | 152.15 |
香草醛 | vanillin | 121-33-5 | C8H8O3 | 152.15 |
—— | 4-hydroxy-3-methoxy-5-cis-propenyl-benzaldehyde | 5438-52-8 | C11H12O3 | 192.214 |
3-烯丙基-4-羟基-5-甲氧基-苯甲醛 | 3-allyl-4-hydroxy-5-methoxybenzaldehyde | 20240-58-8 | C11H12O3 | 192.214 |
3-[(二甲氨基)甲基]-4-羟基-5-甲氧基苯甲醛 | 3-((dimethylamino)methyl)-4-hydroxy-5-methoxybenzaldehyde | 87743-10-0 | C11H15NO3 | 209.245 |
2,4-二(羟基甲基)-6-甲氧基苯酚 | 2-methoxy-4,6-bishydroxymethyl phenol | 3153-97-7 | C9H12O4 | 184.192 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 4,5-dimethoxy-isophthalaldehyde | 10536-24-0 | C10H10O4 | 194.187 |
—— | 4,5-dihydroxyisophthalaldehyde | 116315-07-2 | C8H6O4 | 166.133 |
2-甲氧基-4,6-二甲基苯酚 | 2,6-dimethoxy-4-methylphenol | 2896-66-4 | C9H12O2 | 152.193 |
5-羧基香草酸 | 4-hydroxy-5-methoxyisophthalic acid | 2134-91-0 | C9H8O6 | 212.159 |
3,4-二羟基-5-甲氧基苯甲醛 | 5-hydroxyvanillin | 3934-87-0 | C8H8O4 | 168.149 |
—— | 4-acetoxy-5-methoxy-isophthalaldehyde | 16534-03-5 | C11H10O5 | 222.197 |
—— | 4,5-dimethoxy-isophthalic acid | 485-38-1 | C10H10O6 | 226.186 |
—— | 4-hydroxy-5-methoxy-isophthalic acid dimethyl ester | 50522-16-2 | C11H12O6 | 240.213 |
2,4-二(羟基甲基)-6-甲氧基苯酚 | 2-methoxy-4,6-bishydroxymethyl phenol | 3153-97-7 | C9H12O4 | 184.192 |
4,5-二羟基间苯二甲酸 | 4,5-dihydroxy-1,3-benzenedisulfonic acid | 4707-77-1 | C8H6O6 | 198.132 |
3,5-二甲基苯-1,2-二醇 | 3,5-dimethylcatechol | 2785-75-3 | C8H10O2 | 138.166 |
—— | 4,5-dihydroxy-isophthalic acid-1-methyl ester | 108539-68-0 | C9H8O6 | 212.159 |
—— | 4,5-dihydroxy-isophthalic acid dimethyl ester | 33842-22-7 | C10H10O6 | 226.186 |
3,4-二羟基苯甲醛 | 3,4-dihydroxybenzaldehyde | 139-85-5 | C7H6O3 | 138.123 |
A new series of triazolo[4,3-a]pyimidine derivatives via solid phase multicomponent reaction between 3-oxo-N-(4-(3-oxomorpholino)- phenyl)butanamide, aromatic aldehyde and aminoazole is reported. All the synthesized compounds have been characterized by elemental analysis and spectral analyses. Moreover, the synthesized compounds were also screened for their antibacterial activity against Staphylococcus aureus MTCC-96, Escherichia coli MTCC-443, Bacillus subtilis MTCC-441, Pseudomonas aeruginosa MTCC 1688, and antifungal activity against Aspergillus niger MTCC-282 and Penicillium sp. at different concentration and compared with standards drugs. The minimum inhibition concentration (MIC) of the compounds was studied by micro-broth dilution method.